Medtech company OrthoAlign has received FDA 510(k) clearance for its Lantern ASC system.
The technology is a handheld surgical navigation system designed for total joint arthroplasty procedures, including total and partial knee replacements, according to a June 3 news release from OrthoAlign.
Lantern ASC provides centers with an alternative to robotic systems that require significant investment of capital and long setup times, providing surgeons with accuracy and consistency during surgeries.
Most implant systems are compatible with Lantern ASC, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
